- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic hires Infimed’s Greenway
Bone densitometry firm Hologic found a vice president of business development last month when it named William Greenway to the post. Greenway, formerly president and CEO of image management company InfiMed, will be responsible for the Bedford, MA,
Bone densitometry firm Hologic found a vice president of business development last month when it named William Greenway to the post. Greenway, formerly president and CEO of image management company InfiMed, will be responsible for the Bedford, MA, companys Direct Radiography technology, which it acquired last month from Sterling Diagnostic Imaging (SCAN 6/23/99).
Liverpool, NY-based InfiMed appointed William Yaeger as Greenways replacement. For the past two years, Yaeger has served as InfiMeds senior vice president of operations, and oversaw the development of the companys GoldOne Series of CCD digital x-ray acquisition systems.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
